Lisata Therapeutics (LSTA) to Release Quarterly Earnings on Thursday

Lisata Therapeutics (NASDAQ:LSTA) will release its earnings data after the market closes on Thursday, May 9th. Analysts expect Lisata Therapeutics to post earnings of ($0.73) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Lisata Therapeutics (NASDAQ:LSTA) last posted its quarterly earnings data on Thursday, February 29th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.86) by $0.20. On average, analysts expect Lisata Therapeutics to post $-3 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Lisata Therapeutics Stock Down 0.7 %

LSTA opened at $2.75 on Wednesday. The business’s fifty day simple moving average is $3.00 and its 200 day simple moving average is $2.75. Lisata Therapeutics has a 52 week low of $1.95 and a 52 week high of $4.53. The stock has a market cap of $22.84 million, a PE ratio of -1.07 and a beta of 1.08.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “buy” rating and issued a $15.00 target price on shares of Lisata Therapeutics in a research report on Thursday, April 25th.

About Lisata Therapeutics

Lisata Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease.